Clinical Trial Update: 4-AP Peripheral Nerve Crossover Trial [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating 4-aminopyridine (4-AP) for peripheral nerve injury and crush injury is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crush Injury
• Peripheral Nerve Injury

Drugs mentioned

• 4-aminopyridine (4-aminopyridine)

Snippet

Sponsor: University of Arizona | Conditions: Peripheral Nerve Injury, Crush Injury | Phase 2 | Status: RECRUITING